Gene · 23523
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dose, Kidney Function, and a Drug-Excipient Interaction Impair Mycophenolate Mofetil Prodrug Activation in Kidney Transplant Recipients. | Eur J Drug Metab Pharmacokinet | 2025 | 40506684 | PubTator, text mining | PubMed |
| Structural insights into the interaction of Hir2 and Hpc2 in the yeast Hir histone chaperone complex. | Structure | 2025 | 40449483 | PubTator, text mining | PubMed |
| FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD. | Clin Cancer Res | 2025 | 40435096 | PubTator, text mining | PubMed |
| Prediction of peripheral blood lymphocyte subpopulations after renal transplantation. | Ren Fail | 2025 | 40369954 | PubTator, text mining | PubMed |
| NR3C1 variants and glucocorticoid response in childhood nephrotic syndrome in North India. | BMC Nephrol | 2025 | 40369478 | PubTator, text mining | PubMed |
| Cutaneous complications of cyclosporine: a case of drug-induced folliculitis in atopic dermatitis. | Dermatol Reports | 2025 | 40341665 | PubTator, text mining | PubMed |
| Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland. | Transplant Cell Ther | 2025 | 40334913 | PubTator, text mining | PubMed |
| Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children. | Kidney Int | 2025 | 40254362 | PubTator, text mining | PubMed |
| Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults. | Blood Adv | 2025 | 40249911 | PubTator, text mining | PubMed |
| Calcineurin Inhibitor Associated Nephrotoxicity in Kidney Transplantation-A Transplant Nephrologist's Perspective. | Acta Physiol (Oxf) | 2025 | 40243357 | PubTator, text mining | PubMed |
| Pediatric Case of Calcineurin Inhibitor-Induced Pain Syndrome Diagnosed During Cyclosporine Therapy for Aplastic Anemia. | Cureus | 2025 | 40230761 | PubTator, text mining | PubMed |
| The kidney injury biomarker profile of patients with lupus nephritis remains unchanged with the second-generation calcineurin inhibitor voclosporin. | Front Nephrol | 2025 | 40166657 | PubTator, text mining | PubMed |
| Safety of Everolimus in Lung Transplant Recipients Undergoing Surveillance Bronchoscopy with Transbronchial Forceps Biopsy and Cryobiopsy: A Retrospective Cohort Study. | Exp Clin Transplant | 2025 | 40094256 | PubTator, text mining | PubMed |
| A comprehensive review of the clinical presentation, diagnosis, and treatment of calcineurin inhibitor-induced pain syndrome. | Eur J Med Res | 2025 | 40091077 | PubTator, text mining | PubMed |
| Neurotoxicity of Calcineurin Inhibitors. | Ann Indian Acad Neurol | 2025 | 39901508 | PubTator, text mining | PubMed |
| Obinutuzumab in Difficult to Treat Phospholipase A2 Receptor Positive Membranous Nephropathy: Our Experience at a Tertiary Care Center in North India. | Indian J Nephrol | 2025 | 39872260 | PubTator, text mining | PubMed |
| Integrating rare pathogenic variant prioritization with gene-based association analysis to identify novel genes and relevant multimodal traits for Alzheimer's disease. | Alzheimers Dement | 2025 | 39713882 | PubTator, text mining | PubMed |
| Association of Countries' Atopic Dermatitis Burden and Sociodemographic Index with Topical Calcineurin Inhibitor Utilization. | Dermatitis | 2025 | 38959123 | PubTator, text mining | PubMed |
| Unusual gingival presentation following treatment with pembrolizumab. | Oral Oncol Rep | 2024 | 41853725 | PubTator, text mining | PubMed |
| Disseminated Histoplasmosis with Secondary Hemophagocytic Lymphohistiocytosis in a Renal Transplant Recipient on Belatacept-based Immunosuppression. | J Brown Hosp Med | 2024 | 40026402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23523/papers?page=5